Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain

MLA

Landete L, et al. Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..131a73c812b21268cc73c01af056f08f&authtype=sso&custid=ns315887.

APA

Landete L, Perez-Miralles F, Garcia S, Belenguer A, Gascon F, Andres Dominguez J, Carcelen-Gadea M, Quintanilla-Bordas C, Navarro L, Gabaldon L, & Casanova B. (2021). Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.

Chicago

Landete L, Perez-Miralles F, Garcia S, Belenguer A, Gascon F, Andres Dominguez J, Carcelen-Gadea M, et al. 2021. “Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..131a73c812b21268cc73c01af056f08f&authtype=sso&custid=ns315887.